Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Third Party Analysis for Biotech and Pharma IndustriesKELOWNA, BC / ACCESSWIRE / August 11, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator
DJ Arix Bioscience plc Announces Changes to Board of Directors Arix Bioscience PLC (ARIX) Arix Bioscience plc Announces Changes to Board of Directors 10-Aug-2022 / 07:01 GMT/BST Dissemination of
Significant Milestone Achieved in Commercial Product Development ProgramAbbreviated 505(b)(2) Strategy Confirmed as an Appropriate NDA PathwayKELOWNA, BC / ACCESSWIRE / August 10, 2022 / Lexaria Bioscience
DJ Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics Arix Bioscience PLC (ARIX) Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini
DJ Artios initiates Phase 2 study of Pol? Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer Arix Bioscience PLC (ARIX) Artios initiates Phase 2 study